Jazz Pharmaceuticals PLC (JAZZ) Q2 2021 Earnings Call Transcript

·55-min read
Jazz Pharmaceuticals PLC (JAZZ) Q2 2021 Earnings Call Transcript

Today, Jazz Pharmaceuticals reported its second quarter 2021 financial results. On the call today are Bruce Cozadd, Chairman and Chief Executive Officer; Renee Gala, Executive Vice President and Chief Financial Officer; Dan Swisher, President; and Rob Iannone; Executive Vice President, R&D and Chief Medical Officer; Phil Jochelson, Neuroscience Therapeutic Head will also join the team for Q&A.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting